Therapeutic Asset Ratings

396 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
(+)-VINCRISTINE Uterine Cervical Neoplasms	Eli Lilly and Company	P2	B (60)
Idelalisib Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	Eli Lilly and Company	P4	B (59)
SIMVASTATIN Obesity Disorder	Eli Lilly and Company	P4	B (59)
Retatrutide Type 2 Diabetes Mellitus	Eli Lilly and Company	P3	B (59)
Abemaciclib Prostate Neoplasm	Eli Lilly and Company	P3	B (58)
Eloralintide Obesity Disorder	Eli Lilly and Company	P3	B (58)
Brenipatide Major Depressive Disorder	Eli Lilly and Company	P3	B (57)
DEXAMETHASONE Brain Disorder	Eli Lilly and Company	P3	B (57)
DEXAMETHASONE Dementia	Eli Lilly and Company	P3	B (57)
Orforglipron Hypertensive Disorder	Eli Lilly and Company	P3	B (57)
Retatrutide Cardiovascular Disorder	Eli Lilly and Company	P3	B (57)
Donanemab Cognitive Disorder	Eli Lilly and Company	P2	B (57)
Fepixnebart Diabetic Neuropathy	Eli Lilly and Company	P2	B (57)
ly3556050 Diabetic Neuropathy	Eli Lilly and Company	P2	B (57)
ly3857210 Diabetic Neuropathy	Eli Lilly and Company	P2	B (57)
ly3857210 Osteoarthritis	Eli Lilly and Company	P2	B (57)
(S)-2-(3-Methyl-1-((3-methyl-1,2,4-oxadiazol-5-yl)methyl)-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(6-(2-(trifluoromethyl)pyrimidin-5-yl)pyridin-2-yl)propanamide Diabetic Neuropathy	Eli Lilly and Company	P2	B (57)
(S)-2-(3-Methyl-1-((3-methyl-1,2,4-oxadiazol-5-yl)methyl)-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(6-(2-(trifluoromethyl)pyrimidin-5-yl)pyridin-2-yl)propanamide Osteoarthritis	Eli Lilly and Company	P2	B (57)
(S)-2-(3-Methyl-1-((3-methyl-1,2,4-oxadiazol-5-yl)methyl)-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(6-(2-(trifluoromethyl)pyrimidin-5-yl)pyridin-2-yl)propanamide Osteo Arthritis Knee	Eli Lilly and Company	P2	B (57)
CIS-DIAMMINEDICHLOROPLATINUM II Glioma	Eli Lilly and Company	P1/2	B (57)
INSULIN GLARGINE (SANOFI) Cardiovascular Diseases	Eli Lilly and Company	P3	B (56)
INSULIN GLARGINE (SANOFI) Chronic Kidney Disease	Eli Lilly and Company	P3	B (56)
Itraconazole Non-Small Cell Lung Carcinoma	Eli Lilly and Company	P2	B (56)
INSULIN GLARGINE (SANOFI) Obesity	Eli Lilly and Company	P4	CCC (55)
Durvalumab Glioma	Eli Lilly and Company	P2	CCC (55)

Showing 151 to 175 of 396 assets

PreviousPage 7 of 16Next